tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN
Switzerland Market

Newron Pharmaceuticals SpA (NWRN) Ratios

Compare
3 Followers

Newron Pharmaceuticals SpA Ratios

CH:NWRN's free cash flow for Q2 2025 was €1.00. For the 2025 fiscal year, CH:NWRN's free cash flow was decreased by € and operating cash flow was €0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.51 2.60 0.68 5.65 10.79
Quick Ratio
1.51 2.60 0.68 5.65 10.79
Cash Ratio
0.66 0.29 0.22 2.66 6.85
Solvency Ratio
0.43 0.26 -0.29 -0.34 -0.31
Operating Cash Flow Ratio
0.61 -0.75 -0.35 -2.20 -3.13
Short-Term Operating Cash Flow Coverage
0.73 -1.31 -0.46 0.00 0.00
Net Current Asset Value
€ 656.00K€ -1.35M€ -36.12M€ -22.73M€ -7.95M
Leverage Ratios
Debt-to-Assets Ratio
0.86 0.79 1.87 1.23 0.85
Debt-to-Equity Ratio
33.23 34.62 -1.62 -3.25 13.87
Debt-to-Capital Ratio
0.97 0.97 2.62 1.44 0.93
Long-Term Debt-to-Capital Ratio
0.92 0.96 -6.20 1.45 0.93
Financial Leverage Ratio
38.81 43.83 -0.86 -2.65 16.25
Debt Service Coverage Ratio
0.73 1.15 -0.45 -3.06 -4.09
Interest Coverage Ratio
5.61 6.01 -2.79 -3.05 -4.23
Debt to Market Cap
0.13 0.28 0.51 1.62 1.53
Interest Debt Per Share
2.95 2.95 2.95 2.80 2.58
Net Debt to EBITDA
0.74 1.68 -3.56 -2.42 -1.52
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%100.00%100.00%
EBIT Margin
58.07%50.10%-132.85%-221.94%-207.67%
EBITDA Margin
58.38%50.47%-130.63%-218.62%-206.86%
Operating Profit Margin
58.78%50.93%-128.40%-218.28%-214.46%
Pretax Profit Margin
51.57%41.63%-178.87%-286.71%-258.31%
Net Profit Margin
42.30%30.83%-179.13%-287.05%-258.61%
Continuous Operations Profit Margin
42.30%30.83%-179.13%-287.05%-258.61%
Net Income Per EBT
82.01%74.05%100.15%100.12%100.11%
EBT Per EBIT
87.73%81.74%139.31%131.35%120.45%
Return on Assets (ROA)
41.25%24.79%-62.72%-47.03%-29.52%
Return on Equity (ROE)
1666.25%1086.63%54.25%124.68%-479.59%
Return on Capital Employed (ROCE)
165.16%64.78%380.03%-41.37%-26.39%
Return on Invested Capital (ROIC)
52.29%35.92%-59.97%-41.15%-26.30%
Return on Tangible Assets
41.25%24.79%-62.72%-47.03%-29.52%
Earnings Yield
6.17%8.96%-17.06%-62.62%-53.50%
Efficiency Ratios
Receivables Turnover
7.27 1.21 3.58 3.13 4.41
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
76.77 61.62 22.36 11.56 9.99
Asset Turnover
0.98 0.80 0.35 0.16 0.11
Working Capital Turnover Ratio
2.07 3.63 1.28 0.21 0.17
Cash Conversion Cycle
50.23 301.31 101.96 116.44 82.86
Days of Sales Outstanding
50.23 301.31 101.96 116.44 82.86
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
50.23 301.31 101.96 116.44 82.86
Cash Flow Ratios
Operating Cash Flow Per Share
1.23 -0.95 -0.57 -0.62 -0.64
Free Cash Flow Per Share
1.23 -0.95 -0.57 -0.62 -0.64
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
663.97 -1.35K -921.82 -616.22 -572.25
Capital Expenditure Coverage Ratio
663.97 -1.35K -921.82 -616.22 -572.25
Operating Cash Flow Coverage Ratio
0.47 -0.35 -0.21 -0.24 -0.27
Operating Cash Flow to Sales Ratio
0.41 -0.34 -1.12 -1.82 -1.99
Free Cash Flow Yield
5.97%-9.97%-10.67%-39.77%-41.16%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.23 11.15 -5.86 -1.60 -1.87
Price-to-Sales (P/S) Ratio
6.86 3.44 10.50 4.58 4.83
Price-to-Book (P/B) Ratio
259.77 121.21 -3.18 -1.99 8.96
Price-to-Free Cash Flow (P/FCF) Ratio
16.75 -10.03 -9.37 -2.51 -2.43
Price-to-Operating Cash Flow Ratio
16.73 -10.03 -9.38 -2.52 -2.43
Price-to-Earnings Growth (PEG) Ratio
0.27 -0.06 0.82 -0.10 0.06
Price-to-Fair Value
259.77 121.21 -3.18 -1.99 8.96
Enterprise Value Multiple
12.50 8.49 -11.59 -4.52 -3.85
Enterprise Value
436.72M 220.26M 137.18M 60.17M 45.92M
EV to EBITDA
12.49 8.49 -11.59 -4.52 -3.85
EV to Sales
7.29 4.29 15.15 9.87 7.97
EV to Free Cash Flow
17.80 -12.50 -13.51 -5.42 -4.00
EV to Operating Cash Flow
17.78 -12.50 -13.53 -5.42 -4.01
Tangible Book Value Per Share
0.08 0.08 -1.68 -0.79 0.17
Shareholders’ Equity Per Share
0.08 0.08 -1.68 -0.79 0.17
Tax and Other Ratios
Effective Tax Rate
0.18 0.26 >-0.01 >-0.01 >-0.01
Revenue Per Share
3.00 2.77 0.51 0.34 0.32
Net Income Per Share
1.27 0.85 -0.91 -0.98 -0.84
Tax Burden
0.82 0.74 1.00 1.00 1.00
Interest Burden
0.89 0.83 1.35 1.29 1.24
Research & Development to Revenue
0.22 0.27 1.45 1.98 1.87
SG&A to Revenue
0.12 0.14 0.44 0.58 0.61
Stock-Based Compensation to Revenue
<0.01 <0.01 0.02 0.08 0.13
Income Quality
0.80 -0.82 0.63 0.63 0.77
Currency in EUR